<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--Newton-BB_R012822_1</iati-identifier>
  <reporting-org ref="GB-GOV-13" type="10">
   <narrative xml:lang="EN">Department of Business, Energy and Industrial Strategy</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">The development of a phage food additive with the aim to control Salmonella in swine and poultry</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Animal experimental design to study the role of phage therapy in acute-non typhoidal Salmonellosis Co-investigator: Dr. Parameth Thiennimitr, M.D.,Ph.D.  Address: Department of Microbiology, Faculty of Medicine, Chiang Mai University  Species of animal: 6-8 weeks old female mouse (Mus musculus) C57BL6 strain Protocol (in brief): C57BL/6 mice will be purchased from Nomura Siam International. Mice will be acclimatized for at least 1 week before the experiment day. 24 hour before Salmonella enterica Typhimurium (strain IR715) infection, mouse will be orally gavaged with 20 mg streptomycin sulphate to allow subsequent STM IR715 to establish a colitis. Streptomycin-treated mice will be orally infected with 100 microlitr of 109 cfu/ml STM IR715 solution. Then, 100 microlitr of Salmonella phage solution will be orally gavaged to the infected mice for consecutively 3 days. On day 4 post infection, mice will be euthanized by CO2 and cervical dislocation. Mouse colon content, colon, spleen will be collected for further analysis. Control group (no treatment) of mice will be orally fed with normal saline solution as used as a vehicle for the experimental (phage therapy) groups. Animal protocol approval committee: All animal experiments conduct at Chiang Mai University will be approved by the Chiang Mai University Animal Care and Use Committee (CMU-ACUC). All animal experiments will be performed in the AAALAC-certified biosafety level (BSL) 2 facility located in Chiang Mai University. Numbers of animal in each group is 7. [Calculated followed Bernard, R. (2000). Fundamentals of biostatistics (5th ed). Duxbery: Thomson learning, 308, level of significance = 0.05)]</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">Our aim is to develop a phage food additive to control Salmonella in chickens and pigs and therefore reduce disease and antimicrobial resistance in the human food chain.   We will exploit our novel phage resources, interdisciplinary team and established network of collaborators and animal meat producers to develop and rigorously test resilient, stable phage-cocktails that target relevant Salmonella serotypes from Thai and UK poultry and pig farms.    Objectives In order to deliver the research activities, five major objectives have been identified which will be delivered as discrete work packages, each with an associated milestone as shown on the Gantt Chart attached.   WP1.  Assemble, characterise and evaluate the threat potential of a strain collection of all relevant Salmonella strains in UK/Thailand  WP2.  Assemble phage catalogue based on phages with suitable host range, stability parameters and genome characteristics  WP3. Optimise spray drying parameters, establish how to encapsulate and then spray dry, determine best sugar carrier to minimise phage loss   WP4. Establish efficacy of phages in culture and in chicken and pig cell lines and Galleria   WP5.  Establish how to add phage to feed/water/carcasses, and monitor downstream effects in model systems</narrative>
  </description>
  <participating-org ref="GB-GOV-13" role="1" type="10">
   <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
  </participating-org>
  <participating-org role="3" type="90">
   <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">University of Leicester</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2018-04-01" type="1"></activity-date>
  <activity-date iso-date="2018-04-04" type="2"></activity-date>
  <activity-date iso-date="2021-03-31" type="3"></activity-date>
  <activity-date iso-date="2021-03-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">International Development</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Newton</narrative>
   </person-name>
   <email>gcrf@ukri.org</email>
   <website>https://www.ukri.org/</website>
   <mailing-address>
    <narrative xml:lang="EN">Polaris House, Swindon, SN2 1LF</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <tag code="RI" vocabulary="99" vocabulary-uri="https://devtracker.fcdo.gov.uk/custom-codes">
   <narrative xml:lang="EN">Research and Innovation</narrative>
  </tag>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="1">
   <period-start iso-date="2018-04-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="GBP" value-date="2017-12-19">190308.84</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="GBP" value-date="2017-12-19">179590.84</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="GBP" value-date="2017-12-19">135313.43</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="GBP" value-date="2017-12-19">30668.58</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-19"></transaction-date>
   <value currency="GBP" value-date="2017-12-19">535881.69</value>
   <description>
    <narrative xml:lang="EN">BBSRC Newton Newton Fund Award to University of Leicester</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--Newton-BB/R012822/1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Leicester</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/HTTP" url="http://gtr.rcuk.ac.uk/projects?ref=BB%2FR012822%2F1">
   <title>
    <narrative xml:lang="EN">Abstract/Planned Impact</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-04-04"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.ukri.org/funding/information-for-award-holders/grant-terms-and-conditions/">
   <title>
    <narrative xml:lang="EN">UK Research &amp; Innovation Grant Terms and Conditions</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <conditions attached="1"></conditions>
 </iati-activity>
</iati-activities>
